Bright Historical Financial Ratios
| DRUG Stock | USD 36.50 0.33 0.91% |
Bright Minds is presently reporting on over 81 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 or Book Value Per Share of 2.8 will help investors to properly organize and evaluate Bright Minds Biosciences financial condition quickly.
Bright |
About Bright Financial Ratios Analysis
Bright Minds BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bright Minds investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bright financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bright Minds history.
Bright Minds Financial Ratios Chart
Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Bright Minds' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bright Minds Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. At this time, Bright Minds' Cash Per Share is most likely to increase slightly in the upcoming years. The Bright Minds' current Income Quality is estimated to increase to 0.60, while Free Cash Flow Yield is forecasted to increase to (0.96).
| 2024 | 2025 (projected) | PB Ratio | 1.39 | 1.32 | Capex To Depreciation | 6.2E-5 | 5.5E-5 |
Bright Minds fundamentals Correlations
Click cells to compare fundamentals
Bright Minds Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bright Minds fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 75.07 | 4.18 | 1.99 | 1.21 | 1.39 | 1.32 | |
| Book Value Per Share | 0.57 | 10.81 | 4.27 | 1.77 | 1.6 | 2.8 | |
| Free Cash Flow Yield | (0.005267) | (0.0902) | (0.65) | (0.88) | (1.01) | (0.96) | |
| Operating Cash Flow Per Share | (0.23) | (4.08) | (5.5) | (1.89) | (2.17) | (2.28) | |
| Pb Ratio | 75.07 | 4.18 | 1.99 | 1.21 | 1.39 | 1.32 | |
| Free Cash Flow Per Share | (0.23) | (4.08) | (5.5) | (1.89) | (2.17) | (2.28) | |
| Net Income Per Share | (0.38) | (4.74) | (6.15) | (1.98) | (2.28) | (2.39) | |
| Cash Per Share | 0.62 | 11.06 | 4.74 | 1.84 | 1.65 | 2.93 | |
| Pocfratio | (189.84) | (11.08) | (1.55) | (1.14) | (1.02) | (1.08) | |
| Pfcf Ratio | (189.84) | (11.08) | (1.55) | (1.14) | (1.02) | (1.08) | |
| Income Quality | 0.6 | 0.85 | 0.91 | 0.95 | 0.66 | 0.59 | |
| Ev To Operating Cash Flow | (8.38) | (0.7) | (0.19) | 3.03 | 2.72 | 2.86 | |
| Pe Ratio | (112.67) | (9.53) | (1.38) | (1.08) | (0.98) | (1.02) | |
| Ev To Free Cash Flow | (8.38) | (0.7) | (0.19) | 3.03 | 2.72 | 2.86 | |
| Current Ratio | 31.38 | 8.11 | 24.26 | 11.32 | 10.19 | 11.08 | |
| Tangible Book Value Per Share | 0.57 | 10.81 | 4.27 | 1.77 | 1.6 | 2.8 | |
| Shareholders Equity Per Share | 0.57 | 10.81 | 4.27 | 1.77 | 1.6 | 2.8 | |
| Graham Net Net | 0.51 | 10.75 | 4.16 | 1.77 | 1.59 | 2.75 | |
| Roic | (0.65) | (0.44) | (1.4) | (1.1) | (1.27) | (1.33) | |
| Roe | (0.67) | (0.44) | (1.44) | (1.12) | (1.28) | (1.35) | |
| Return On Tangible Assets | (0.55) | (0.42) | (1.26) | (1.07) | (1.23) | (1.29) | |
| Earnings Yield | (0.008876) | (0.1) | (0.72) | (0.92) | (1.06) | (1.01) | |
| Price Earnings Ratio | (112.67) | (9.53) | (1.38) | (1.08) | (0.98) | (1.02) | |
| Price Book Value Ratio | 75.07 | 4.18 | 1.99 | 1.21 | 1.39 | 1.32 | |
| Price To Operating Cash Flows Ratio | (189.84) | (11.08) | (1.55) | (1.14) | (1.02) | (1.08) | |
| Price To Free Cash Flows Ratio | (189.84) | (11.08) | (1.55) | (1.14) | (1.02) | (1.08) | |
| Company Equity Multiplier | 1.03 | 1.15 | 1.04 | 1.1 | 1.27 | 1.25 | |
| Quick Ratio | 31.38 | 8.11 | 24.26 | 11.32 | 10.19 | 11.08 | |
| Cash Ratio | 5.3 | 30.94 | 7.9 | 24.03 | 10.82 | 9.74 | |
| Price To Book Ratio | 75.07 | 4.18 | 1.99 | 1.21 | 1.39 | 1.32 |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.